BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 24885390)

  • 1. Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5--implications for dementia with Lewy bodies.
    Overk CR; Cartier A; Shaked G; Rockenstein E; Ubhi K; Spencer B; Price DL; Patrick C; Desplats P; Masliah E
    Mol Neurodegener; 2014 May; 9():18. PubMed ID: 24885390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity.
    Price DL; Rockenstein E; Ubhi K; Phung V; MacLean-Lewis N; Askay D; Cartier A; Spencer B; Patrick C; Desplats P; Ellisman MH; Masliah E
    PLoS One; 2010 Nov; 5(11):e14020. PubMed ID: 21103359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human amyloid beta and α-synuclein co-expression in neurons impair behavior and recapitulate features for Lewy body dementia in Caenorhabditis elegans.
    Huang X; Wang C; Chen L; Zhang T; Leung KL; Wong G
    Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166203. PubMed ID: 34146705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.
    Rockenstein E; Nuber S; Overk CR; Ubhi K; Mante M; Patrick C; Adame A; Trejo-Morales M; Gerez J; Picotti P; Jensen PH; Campioni S; Riek R; Winkler J; Gage FH; Winner B; Masliah E
    Brain; 2014 May; 137(Pt 5):1496-513. PubMed ID: 24662516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model.
    Spencer B; Desplats PA; Overk CR; Valera-Martin E; Rissman RA; Wu C; Mante M; Adame A; Florio J; Rockenstein E; Masliah E
    J Neurosci; 2016 Jul; 36(30):7971-84. PubMed ID: 27466341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
    Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
    Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal Reduction of α-Synuclein via RNA Interference Improves Neuropathology in Alzheimer's Disease Mice.
    Leitão ADG; Spencer B; Sarsoza F; Ngolab J; Amalraj J; Masliah E; Wu C; Rissman RA
    J Alzheimers Dis; 2023; 95(1):349-361. PubMed ID: 37522208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axonopathy in an α-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated α-synuclein.
    Games D; Seubert P; Rockenstein E; Patrick C; Trejo M; Ubhi K; Ettle B; Ghassemiam M; Barbour R; Schenk D; Nuber S; Masliah E
    Am J Pathol; 2013 Mar; 182(3):940-53. PubMed ID: 23313024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of amyloid-β plaque formation by α-synuclein.
    Bachhuber T; Katzmarski N; McCarter JF; Loreth D; Tahirovic S; Kamp F; Abou-Ajram C; Nuscher B; Serrano-Pozo A; Müller A; Prinz M; Steiner H; Hyman BT; Haass C; Meyer-Luehmann M
    Nat Med; 2015 Jul; 21(7):802-7. PubMed ID: 26099047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?
    Fujita M; Sekigawa A; Sekiyama K; Sugama S; Hashimoto M
    J Neurol; 2009 Aug; 256 Suppl 3():286-92. PubMed ID: 19711118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentivirus mediated delivery of neurosin promotes clearance of wild-type α-synuclein and reduces the pathology in an α-synuclein model of LBD.
    Spencer B; Michael S; Shen J; Kosberg K; Rockenstein E; Patrick C; Adame A; Masliah E
    Mol Ther; 2013 Jan; 21(1):31-41. PubMed ID: 22508489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation.
    Dufty BM; Warner LR; Hou ST; Jiang SX; Gomez-Isla T; Leenhouts KM; Oxford JT; Feany MB; Masliah E; Rohn TT
    Am J Pathol; 2007 May; 170(5):1725-38. PubMed ID: 17456777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson's disease.
    Zhang YN; Fan JK; Gu L; Yang HM; Zhan SQ; Zhang H
    J Neuroinflammation; 2021 Jan; 18(1):23. PubMed ID: 33461598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models.
    Iba M; Kim C; Sallin M; Kwon S; Verma A; Overk C; Rissman RA; Sen R; Sen JM; Masliah E
    J Neuroinflammation; 2020 Jul; 17(1):214. PubMed ID: 32680537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying regional α -synuclein, amyloid β, and tau accumulation in lewy body dementia.
    Miller RL; Dhavale DD; O'Shea JY; Andruska KM; Liu J; Franklin EE; Buddhala C; Loftin SK; Cirrito JR; Perrin RJ; Cairns NJ; Campbell MC; Perlmutter JS; Kotzbauer PT
    Ann Clin Transl Neurol; 2022 Feb; 9(2):106-121. PubMed ID: 35060360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-β and α-synuclein pathologies in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies.
    Fixemer S; Ameli C; Hammer G; Salamanca L; Uriarte Huarte O; Schwartz C; Gérardy JJ; Mechawar N; Skupin A; Mittelbronn M; Bouvier DS
    Acta Neuropathol Commun; 2022 Mar; 10(1):36. PubMed ID: 35296366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amitriptyline improves cognitive and neuronal function in a rat model that mimics dementia with lewy bodies.
    Lin CL; Zheng TL; Tsou SH; Chang HM; Tseng LH; Yu CH; Hung CS; Ho YJ
    Behav Brain Res; 2022 Oct; 435():114035. PubMed ID: 35926562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal Rifampicin Improves Cognition in a Mouse Model of Dementia with Lewy Bodies by Reducing α-Synuclein Oligomers.
    Umeda T; Hatanaka Y; Sakai A; Tomiyama T
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein aggregates are excluded from calbindin-D28k-positive neurons in dementia with Lewy bodies and a unilateral rotenone mouse model.
    Rcom-H'cheo-Gauthier AN; Davis A; Meedeniya ACB; Pountney DL
    Mol Cell Neurosci; 2016 Dec; 77():65-75. PubMed ID: 27746320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model.
    Lloyd GM; Dhillon JS; Gorion KM; Riffe C; Fromholt SE; Xia Y; Giasson BI; Borchelt DR
    Mol Neurodegener; 2021 Sep; 16(1):63. PubMed ID: 34503546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.